Insider · CIK 0001873394
Natarajan Sethuraman
Files at TRDA (Entrada Therapeutics, Inc.). First filing Oct 18, 2024, latest Dec 3, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TRDA: Entrada Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | Entrada Therapeutics, Inc. | $321k 15,891 shares | -10% | - | |
| 17Weak | Entrada Therapeutics, Inc. | $82k 4,109 shares | -2% | - | |
| 23Weak | Entrada Therapeutics, Inc. | $339k 18,219 shares | -10% | - | |
| 0Weak | Entrada Therapeutics, Inc. | $11k 600 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 12, 2024 | TRDA ENTRADA THERAPEUTICS INC | 18,762 0.05% of outstanding | $372k | Nov 11, 2024 | $399k |
| Oct 16, 2024 | TRDA ENTRADA THERAPEUTICS INC | 20,057 0.05% of outstanding | $352k | Oct 16, 2024 | $49k |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -2,079 | $7.14 | $15k | 214,238 | 39 d ago |
| Mar 1, 2026 | TRDA Entrada Therapeutics, Inc. | AGrant or award Common Stock | +55,800 | $0.00 | $0 | 253,699 | Mar 3, 2026 |
| Mar 2, 2026 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -3,898 | $11.66 | $45k | 249,801 | Mar 3, 2026 |
| Mar 3, 2026 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -7,577 | $11.76 | $89k | 242,224 | Mar 3, 2026 |
| Mar 1, 2026 | TRDA Entrada Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +83,200 | $0.00 | $0 | 83,200 | Mar 3, 2026 |
| Sep 2, 2025 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -1,760 | $5.43 | $9,557 | 197,899 | Sep 4, 2025 |
| Mar 1, 2025 | TRDA Entrada Therapeutics, Inc. | AGrant or award Common Stock | +60,800 | $0.00 | $0 | 205,797 | Mar 4, 2025 |
| Mar 3, 2025 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -6,138 | $11.68 | $72k | 199,659 | Mar 4, 2025 |
| Mar 1, 2025 | TRDA Entrada Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,800 | $0.00 | $0 | 90,800 | Mar 4, 2025 |
| Nov 29, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $20.00 | $2,000 | 160,788 | Dec 3, 2024 |
| Dec 2, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,088 | $20.26 | $83k | 156,700 | Dec 3, 2024 |
| Dec 3, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,703 | $20.15 | $236k | 144,997 | Dec 3, 2024 |
| Nov 11, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,409 | $20.01 | $28k | 163,588 | Nov 13, 2024 |
| Nov 13, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,700 | $20.04 | $54k | 160,888 | Nov 13, 2024 |
| Nov 4, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -749 | $18.02 | $13k | 182,467 | Nov 6, 2024 |
| Nov 5, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,171 | $18.18 | $94k | 177,296 | Nov 6, 2024 |
| Nov 6, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,554 | $18.71 | $179k | 167,742 | Nov 6, 2024 |
| Nov 6, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,745 | $19.32 | $53k | 164,997 | Nov 6, 2024 |
| Oct 16, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -600 | $18.00 | $11k | 183,216 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.